Cardiovascular disease is a complexity of conditions comprising heart failure, cardiomyopathy, congenital heart disease and coronary heart disease etc. They impose severe health complications and remain challenge on treatments for the affected patients. Many risk factors are linked with the development of cardiovascular diseases include smoking, alcohol, stress, insufficient physical activity, poor diet, high blood…
BOSTON – The potential impact of the patient-clinician relationship on a patient’s response to treatment is widely accepted. But until now, little was known about which parts of the brain may play a role in that interaction and which specific behaviors can influence clinical response, which is critically important to optimizing patient-clinician interactions for clinical…
A team of scientists at Texas A&M University, Baylor College of Medicine and Texas Children’s Hospital have developed a way to more accurately both detect and monitor a common type of pediatric brain cancer, setting the stage for giving clinicians a real-time view into how the cancer responds to treatment. Medulloblastoma (MB), the most common…
JACKSONVILLE, Fla. — Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3) ? a disease that has no cure. They also have clarified the role of a gene target associated with the disease. The inherited disease is linked to a mutation…
Approximately 30% of breast cancer patients who receive chemotherapy treatment gain weight, though it is unclear why this phenomenon occurs in some women but not in others. Beyond weight gain, chemotherapy is also known to increase the risk of high blood pressure and glucose intolerance, a prediabetes condition. Although this is a familiar phenomenon, the…
University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus – health care workers. The pre-exposure prophylaxis trial results, which were published in Clinical Infectious Diseases, determined that taking 400mg of hydroxychloroquine once or twice weekly did not prevent the development…
TUCSON, Ariz. and WASHINGTON, D.C. October 21, 2020 — The Critical Path Institute (C-Path) and the National Organization for Rare Disorders (NORD®) hosted the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) 2020 Virtual Workshop on Monday, October 19. The platform, funded by a cooperative agreement through the U.S. Food and Drug Administration (FDA), serves…
California health officials issued long-awaited guidance for reopening theme parks in the state on Tuesday, setting targets for when attractions like Disneyland Resort, in Anaheim, and Universal Studios Hollywood, in Los Angeles, can open their doors. For the big parks, it could be a long road: their counties must reach the least-restrictive “yellow” tier of…
The coronavirus pandemic caused nearly 300,000 deaths in the United States through early October, federal researchers said on Tuesday. The new tally includes not only deaths known to have been directly caused by the coronavirus, but also roughly 100,000 fatalities that are indirectly related and would not have occurred if not for the virus. The…
On Sept. 23, Dr. Stephen M. Hahn left a virtual meeting of the White House’s coronavirus task force to take a call from the president’s chief of staff, Mark Meadows. Mr. Meadows was angry with Dr. Hahn, the head of the Food and Drug Administration, for pushing new guidelines for vaccine developers, according to two…